LogicBio Therapeutics to Participate in Upcoming Investor Conferences
Jefferies Virtual Healthcare Conference ,Friday, June 4 , at9:30 AM ET .JMP Securities Life Sciences Conference ,Wednesday, June 16 , at2:00 PM ET .
Where applicable, live webcasts of the fireside chats can be accessed through the Investors section of the Company's website at https://investor.logicbio.com.
About
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The Company's proprietary GeneRide™ platform is a new approach to precise gene insertion that has the potential to harness a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The Company is based in Lexington, MA. For more information, visit https://www.logicbio.com/, which does not form a part of this release.
Media Contacts:
Berry & Company Public Relations
W: 212-253-8881
C: 614-580-2048
adaley@berrypr.com
Berry & Company Public Relations
W: 212-253-8881
C: 203-218-9180
jurban@berrypr.com
Investor Contacts:
(617) 901-7698
matt@gilmartinir.com
View original content:http://www.prnewswire.com/news-releases/logicbio-therapeutics-to-participate-in-upcoming-investor-conferences-301303288.html
SOURCE